Methylthioninium
IMSN002
Phase 3 small_molecule completed
Quick answer
Methylthioninium for Breast Cancer is a Phase 3 program (small_molecule) at Shandong Suncadia Medicine Co., with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Shandong Suncadia Medicine Co.,
- Indication
- Breast Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed